Abstract 5696: Evaluating determinants for enhanced activity of MM-398/PEP02; a novel nanotherapeutic encapsulation of irinotecan (CPT-11)
Year: 2012
Type: conference-abstract
Source: Cancer Research
Institution: Merrimack Pharmaceuticals (United States)
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2328015443
